{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02917681",
      "OrgStudyIdInfo": {
        "OrgStudyId": "401922/2014-6"
      },
      "Organization": {
        "OrgFullName": "University of Sao Paulo General Hospital",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2016",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 2016"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "February 2019",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "August 2019",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "September 26, 2016",
      "StudyFirstSubmitQCDate": "September 27, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "September 28, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "September 27, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 28, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Gerson Chadi",
        "ResponsiblePartyInvestigatorTitle": "Professor",
        "ResponsiblePartyInvestigatorAffiliation": "University of Sao Paulo General Hospital"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University of Sao Paulo General Hospital",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Pontifícia Universidade Católica do Paraná",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The study aims to evaluate primarily safety of two injections of autologous mesenchymal stem cells in Amyotrophic Lateral Sclerosis patients. Secondary outcomes of efficacy will also be evaluated",
      "DetailedDescription": "The study is an open-label, unmasked, uncontrolled phase I and II trial to evaluate safety and efficacy of two injections of autologous mesenchymal stem cells (MSC) in Amyotrophic Lateral Sclerosis (ALS) patients. Patients will be recruited trough a web-based registration system, open for all ALS Brazilian patients. The patients will be enrolled after in-person screening at the University of Sao Paulo Medical School Clinics Hospital and inclusion criteria fulfilled. There will be 9 national calls for registration, two months apart each. The enrolled patients will be followed for 3 months before bone marrow aspiration (BMA). Patients will receive 2 intrathecal MSC injections, 1 and 2 months after BMA. The patients will be followed for 6 months after the interventions."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "AMYOTROPHIC LATERAL SCLEROSIS"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "ALS",
          "mesenchymal stem cells",
          "intrathecal"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "28",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MSC injection",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients will be followed for 3 months before bone marrow aspiration (BMA). Patients will receive 2 intrathecal MSC injections, 1 and 2 months after BMA. The patients will be followed for 6 months after the interventions.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Two intrathecal MSC injections"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "Two intrathecal MSC injections",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSC injection"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety",
            "PrimaryOutcomeDescription": "Clinical and laboratory monitoring of possible reactions to intrathecal MSC delivery",
            "PrimaryOutcomeTimeFrame": "10 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Change in Amyotrophic Lateral Sclerosis Functional Rating Scale Revised (ALSFRS-R)",
            "SecondaryOutcomeDescription": "Specific scale for assessing ALS disease progression",
            "SecondaryOutcomeTimeFrame": "10 months"
          },
          {
            "SecondaryOutcomeMeasure": "Change in Handheld dynamometry",
            "SecondaryOutcomeTimeFrame": "10 months"
          },
          {
            "SecondaryOutcomeMeasure": "Change in Electrical Impedance Myography",
            "SecondaryOutcomeTimeFrame": "10 months"
          },
          {
            "SecondaryOutcomeMeasure": "Change in Forced Vital Capacity (FVC)",
            "SecondaryOutcomeTimeFrame": "10 months"
          },
          {
            "SecondaryOutcomeMeasure": "Change in Isometric Strength",
            "SecondaryOutcomeTimeFrame": "10 months"
          },
          {
            "SecondaryOutcomeMeasure": "Changes in morphometric parameters of MRI of encephalon and spinal cord",
            "SecondaryOutcomeTimeFrame": "10 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAge between 18 and 70\nPossible, probable or definite ALS following El Escorial Revised Criteria (Brooks, 2000)\nALSFRS-r ≥30 at enrollment\nForced Vital Capacity ≥65% of the height and weight standard\nNo-pregnancy agreement\nRegional accessibility to the study site\nCapability to give away agreed consensus\nPatients will be followed at Academic Institutions at their hometown\n\nExclusion Criteria:\n\nPrevious cellular therapy\nIncapacity to lay still during bone marrow aspirate or intrathecal MSC injections\nPersonal history of auto-Immune, myeloproliferative or myelodysplastic diseases, leukemia, lymphoma, whole-body irradiation, hip fracture, severe scoliosis or incapacity to undergo any of the study's proposed procedures\nAny other disease that may interfere with the study\nAny other neurological diseases\nAspartate or alanine aminotransferases elevated >3x normality upper limit\nSerum creatinine >2x normality upper limit\nHepatitis B and C, HIV, HTLV I and II and syphilis\nImmunosuppressant drug use within 6 weeks from the study's screening\nPregnancy or breast-feeding\nAcquired or inherited Immunodeficiency\nParticipation in other clinical trials\nNon-invasive ventilation, tracheostomy or diaphragm pacing\nSubstance abuse within one year and other unstable mental health diseases according to researcher's judgement\nGastrostomy or any alternative feeding means\nInappropriate in-vitro MSC expansion",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Fabrício Castro Borba, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "551130617460",
            "CentralContactEMail": "contato@projetoelabrasil.com.br"
          },
          {
            "CentralContactName": "Jéssica Ruivo Maximino, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "551130617460",
            "CentralContactEMail": "contato@projetoelabrasil.com.br"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Gerson Chadi, MD, PhD",
            "OverallOfficialAffiliation": "Full Professor",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University of Sao Paulo School of Medicine Clinics Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Sao Paulo",
            "LocationState": "SP",
            "LocationZip": "05403000",
            "LocationCountry": "Brazil"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000016472",
            "ConditionMeshTerm": "Motor Neuron Disease"
          },
          {
            "ConditionMeshId": "D000000690",
            "ConditionMeshTerm": "Amyotrophic Lateral Sclerosis"
          },
          {
            "ConditionMeshId": "D000012598",
            "ConditionMeshTerm": "Sclerosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000019636",
            "ConditionAncestorTerm": "Neurodegenerative Diseases"
          },
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000009468",
            "ConditionAncestorTerm": "Neuromuscular Diseases"
          },
          {
            "ConditionAncestorId": "D000013118",
            "ConditionAncestorTerm": "Spinal Cord Diseases"
          },
          {
            "ConditionAncestorId": "D000002493",
            "ConditionAncestorTerm": "Central Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000057177",
            "ConditionAncestorTerm": "TDP-43 Proteinopathies"
          },
          {
            "ConditionAncestorId": "D000057165",
            "ConditionAncestorTerm": "Proteostasis Deficiencies"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14567",
            "ConditionBrowseLeafName": "Sclerosis",
            "ConditionBrowseLeafAsFound": "Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18031",
            "ConditionBrowseLeafName": "Motor Neuron Disease",
            "ConditionBrowseLeafAsFound": "Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3176",
            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafAsFound": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M20711",
            "ConditionBrowseLeafName": "Neurodegenerative Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11563",
            "ConditionBrowseLeafName": "Neuromuscular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M15067",
            "ConditionBrowseLeafName": "Spinal Cord Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4894",
            "ConditionBrowseLeafName": "Central Nervous System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M27912",
            "ConditionBrowseLeafName": "TDP-43 Proteinopathies",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M27900",
            "ConditionBrowseLeafName": "Proteostasis Deficiencies",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4699",
            "ConditionBrowseLeafName": "Primary Lateral Sclerosis",
            "ConditionBrowseLeafAsFound": "Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T349",
            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafAsFound": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}